Feedback / Questions
Reyobiq (rhenium Re186 obisbemeda) - Plus Therap
CA2024-LM-001: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
(clinicaltrials.gov)
-
Aug 2, 2025 -
P1 | N=24 | Recruiting | Sponsor: Plus Therapeutics
New P1 trial
•
Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07098806
Aug 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next